FDA grants accelerated approval to new treatment for advanced ovarian cancer

By December 19, 2016 FDA Press Releases No Comments

The U.S. Food and Drug Administration today granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian cancer.
Source: FDA Press Releases